Annual Accounts Payable
$1.23 M
+$38.00 K+3.19%
December 31, 2022
Summary
- As of February 26, 2025, BLPH annual accounts payable is $1.23 million, with the most recent change of +$38.00 thousand (+3.19%) on December 31, 2022.
- During the last 3 years, BLPH annual accounts payable has fallen by -$1.88 million (-60.40%).
Performance
BLPH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$612.00 K
-$1.27 M-67.57%
September 30, 2023
Summary
- As of February 26, 2025, BLPH quarterly accounts payable is $612.00 thousand, with the most recent change of -$1.27 million (-67.57%) on September 30, 2023.
- Over the past year, BLPH quarterly accounts payable has dropped by -$913.00 thousand (-59.87%).
Performance
BLPH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BLPH Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.2% | -59.9% |
| 3 y3 years | -60.4% | -59.9% |
| 5 y5 years | -68.1% | -86.0% |
BLPH Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -3.1% | -72.1% | at low |
| 5 y | 5-year | -67.0% | -3.1% | -84.0% | at low |
| alltime | all time | -68.1% | -69.4% | -86.7% | -38.6% |
Bellerophon Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $612.00 K(-67.6%) |
| Jun 2023 | - | $1.89 M(+76.4%) |
| Mar 2023 | - | $1.07 M(-13.0%) |
| Dec 2022 | $1.23 M(+3.2%) | $1.23 M(-19.3%) |
| Sep 2022 | - | $1.52 M(-24.0%) |
| Jun 2022 | - | $2.01 M(-8.5%) |
| Mar 2022 | - | $2.19 M(+84.0%) |
| Dec 2021 | $1.19 M(-68.0%) | $1.19 M(-6.7%) |
| Sep 2021 | - | $1.28 M(-48.6%) |
| Jun 2021 | - | $2.48 M(-34.8%) |
| Mar 2021 | - | $3.81 M(+2.2%) |
| Dec 2020 | $3.73 M(+19.9%) | $3.73 M(-2.5%) |
| Sep 2020 | - | $3.82 M(+34.6%) |
| Jun 2020 | - | $2.84 M(+27.8%) |
| Mar 2020 | - | $2.22 M(-28.5%) |
| Dec 2019 | $3.11 M(+12.7%) | $3.11 M(+37.2%) |
| Sep 2019 | - | $2.26 M(-19.8%) |
| Jun 2019 | - | $2.82 M(+7.0%) |
| Mar 2019 | - | $2.64 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $2.75 M(-28.5%) | $2.75 M(-37.0%) |
| Sep 2018 | - | $4.37 M(+7.8%) |
| Jun 2018 | - | $4.06 M(-11.7%) |
| Mar 2018 | - | $4.59 M(+19.2%) |
| Dec 2017 | $3.85 M(+37.3%) | $3.85 M(+39.9%) |
| Sep 2017 | - | $2.75 M(-2.8%) |
| Jun 2017 | - | $2.83 M(-28.1%) |
| Mar 2017 | - | $3.94 M(+40.5%) |
| Dec 2016 | $2.81 M(+74.0%) | $2.81 M(+25.6%) |
| Sep 2016 | - | $2.23 M(+10.6%) |
| Jun 2016 | - | $2.02 M(+215.1%) |
| Mar 2016 | - | $641.00 K(-60.3%) |
| Dec 2015 | $1.61 M(+329.0%) | $1.61 M(+72.7%) |
| Sep 2015 | - | $934.00 K(-3.3%) |
| Jun 2015 | - | $966.00 K(+46.6%) |
| Mar 2015 | - | $659.00 K(+75.3%) |
| Dec 2014 | $376.00 K(-72.5%) | $376.00 K(-57.4%) |
| Sep 2014 | - | $882.00 K(-35.5%) |
| Dec 2013 | $1.37 M(-8.0%) | $1.37 M |
| Dec 2012 | $1.49 M | - |
FAQ
- What is Bellerophon Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual accounts payable year-on-year change?
- What is Bellerophon Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly accounts payable year-on-year change?
What is Bellerophon Therapeutics annual accounts payable?
The current annual accounts payable of BLPH is $1.23 M
What is the all time high annual accounts payable for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual accounts payable is $3.85 M
What is Bellerophon Therapeutics annual accounts payable year-on-year change?
Over the past year, BLPH annual accounts payable has changed by +$38.00 K (+3.19%)
What is Bellerophon Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BLPH is $612.00 K
What is the all time high quarterly accounts payable for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly accounts payable is $4.59 M
What is Bellerophon Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BLPH quarterly accounts payable has changed by -$913.00 K (-59.87%)